Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

U.S. Bankruptcy Judge Christopher Lopez heard opening statements on Tuesday in a two-week trial over the fate of Johnson & Johnson's third talcum powder bankruptcy.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company ... company’s board and have not taken distributions from Purdue since before the bankruptcy filing. The company ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

Purdue Pharma’s owners from the Sackler family ... reopening a path to end the longest and costliest corporate bankruptcy case stemming from the U.S. opioid crisis. The Sackler family members ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

NEW YORK, Jan 23 (Reuters) - Purdue Pharma and its Sackler family owners ... company's previous attempt to resolve the lawsuits in a bankruptcy settlement that would have granted the Sacklers ...